BioPharmSignal logoBioPharmSignal

Biotech News

iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

iSpecimen (ISPC)iSpecimenFinancing

WOBURN, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists...

Related news

ISPCiSpecimen2024-10-30 08:30 EST

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

ISPCiSpecimen2024-11-07 07:30 EST

iSpecimen Releases Cancer Biospecimen Offering; Orders Anticipated of Over $9,500,000 Annually

View all latest news

iSpecimen

iSpecimen is a healthcare data and biospecimen marketplace company that connects researchers with human biospecimens and related services. Its role is to support research and translational work rather than develop therapies.

Recent company news

ISPCiSpecimen2025-01-16 16:01 EST

iSpecimen Secures Suppliers for COVID-style hMPV Outbreak

ISPCiSpecimen2024-12-20 08:30 EST

iSpecimen Will Serve as a Preferred Provider of Cancer Biospecimens

ISPCiSpecimen2024-12-13 07:30 EST

iSpecimen Reports Positive Results on Next Day Quote Program for Researchers and Providers

ISPCiSpecimen2024-12-12 17:11 EST

iSpecimen Appoints Robert Lim as CEO and Director

ISPCiSpecimen2024-11-08 07:30 EST

iSpecimen Named Top Competitor in $4.4 Billion USD Market

Stock data

Close
1.69 USD
Market cap
4.41M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States